<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35155571</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-889X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in molecular biosciences</Title><ISOAbbreviation>Front Mol Biosci</ISOAbbreviation></Journal><ArticleTitle>Cancer Occurrence as the Upcoming Complications of COVID-19.</ArticleTitle><Pagination><StartPage>813175</StartPage><MedlinePgn>813175</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">813175</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmolb.2021.813175</ELocationID><Abstract><AbstractText>Previous studies suggested that patients with comorbidities including cancer had a higher risk of mortality or developing more severe forms of COVID-19. The interaction of cancer and COVID-19 is unrecognized and potential long-term effects of COVID-19 on cancer outcome remain to be explored. Furthermore, whether COVID-19 increases the risk of cancer in those without previous history of malignancies, has not yet been studied. Cancer progression, recurrence and metastasis depend on the complex interaction between the tumor and the host inflammatory response. Extreme proinflammatory cytokine release (cytokine storm) and multi-organ failure are hallmarks of severe COVID-19. Besides impaired T-Cell response, elevated levels of cytokines, growth factors and also chemokines in the plasma of patients in the acute phase of COVID-19 as well as tissue damage and chronic low-grade inflammation in "long COVID-19" syndrome may facilitate cancer progression and recurrence. Following a systemic inflammatory response syndrome, some counterbalancing compensatory anti-inflammatory mechanisms will be activated to restore immune homeostasis. On the other hand, there remains the possibility of the integration of SARS- CoV-2 into the host genome, which potentially may cause cancer. These mechanisms have also been shown to be implicated in both tumorigenesis and metastasis. In this review, we are going to focus on potential mechanisms and the molecular interplay, which connect COVID-19, inflammation, and immune-mediated tumor progression that may propose a framework to understand the possible role of COVID-19 infection in tumorgenesis and cancer progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Rahimmanesh, Shariati, Dana, Esmaeili, Vaseghi and Haghjooy Javanmard.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahimmanesh</LastName><ForeName>Ilnaz</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shariati</LastName><ForeName>Laleh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dana</LastName><ForeName>Nasim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esmaeili</LastName><ForeName>Yasaman</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biosensor Research Center, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaseghi</LastName><ForeName>Golnaz</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haghjooy Javanmard</LastName><ForeName>Shaghayegh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Mol Biosci</MedlineTA><NlmUniqueID>101653173</NlmUniqueID><ISSNLinking>2296-889X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">immune homeostasis</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35155571</ArticleId><ArticleId IdType="pmc">PMC8831861</ArticleId><ArticleId IdType="doi">10.3389/fmolb.2021.813175</ArticleId><ArticleId IdType="pii">813175</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdel-Moneim A., Hosni A. (2021). &#x201c;Insights into the Possible Impact of COVID-19 on the Endocrine System,&#x201d; in COVID-19 Pandemic and Male Fertility: Clinical Manifestations and Pathogenic Mechanisms (Archives of Physiology and Biochemistry; ), 1&#x2013;9. 10.1080/13813455.2021.1890131</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13813455.2021.1890131</ArticleId><ArticleId IdType="pubmed">33653188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W., et al. (2020). Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: a Report of 1014 Cases. Radiology 296 (2), E32&#x2013;E40. 10.1148/radiol.2020200642</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200642</ArticleId><ArticleId IdType="pmc">PMC7233399</ArticleId><ArticleId IdType="pubmed">32101510</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Baadani A., Eltayeb N., Alsufyani E., Albahrani S., Basheri S., Albayat H., et al. (2021). Efficacy of Tocilizumab in Patients with Severe COVID-19: Survival and Clinical Outcomes. J. Infect. Public Health 14 (8), 1021&#x2013;1027. 10.1016/j.jiph.2021.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.05.015</ArticleId><ArticleId IdType="pmc">PMC8166045</ArticleId><ArticleId IdType="pubmed">34153727</ArticleId></ArticleIdList></Reference><Reference><Citation>Astuti I., Ysrafil (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An Overview of Viral Structure and Host Response. Diabetes Metab. Syndr. Clin. Res. Rev. 14 (4), 407&#x2013;412. 10.1016/j.dsx.2020.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.020</ArticleId><ArticleId IdType="pmc">PMC7165108</ArticleId><ArticleId IdType="pubmed">32335367</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadbakht J., Khoramian D., Lajevardi Z. S., Elikaii F., Aflatoonian A. H., Farhood B., et al. (2021). A Review on Chest CT Scanning Parameters Implemented in COVID-19 Patients: Bringing Low-Dose CT Protocols into Play. Egypt. J. Radiol. Nucl. Med. 52 (1), 13. 10.1186/s43055-020-00400-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-020-00400-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj V., Gadi N., Spihlman A. P., Wu S. C., Choi C. H., Moulton V. R. (2021). Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections. Front. Physiol. 11, 1793. 10.3389/fphys.2020.571416</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.571416</ArticleId><ArticleId IdType="pmc">PMC7835928</ArticleId><ArticleId IdType="pubmed">33510644</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnabei L., Laplantine E., Mbongo W., Rieux-Laucat F., Weil R. (2021). NF-&#x3ba;B: At the Borders of Autoimmunity and Inflammation. Front. Immunol. 12, 716469. 10.3389/fimmu.2021.716469</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.716469</ArticleId><ArticleId IdType="pmc">PMC8381650</ArticleId><ArticleId IdType="pubmed">34434197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayati A., Kumar R., Francis V., McPherson P. S. (2020). SARS-CoV-2 Uses Clathrin-Mediated Endocytosis to Gain Access into Cells, BioRxiv. J. Biol. Chem. 296, 100306. 10.1016/j.jbc.2021.100306</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100306</ArticleId><ArticleId IdType="pmc">PMC7816624</ArticleId><ArticleId IdType="pubmed">33476648</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharti R., Dey G., Mandal M. (2016). Cancer Development, Chemoresistance, Epithelial to Mesenchymal Transition and Stem Cells: A Snapshot of IL-6 Mediated Involvement. Cancer Lett. 375 (1), 51&#x2013;61. 10.1016/j.canlet.2016.02.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2016.02.048</ArticleId><ArticleId IdType="pubmed">26945971</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B. E., Liu W.-C., Uhl S., Hoagland D., M&#xf8;ller R., et al. (2020). Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell 181 (5), 1036&#x2013;1045. 10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonjardim C. A. (2005). Interferons (IFNs) Are Key Cytokines in Both Innate and Adaptive Antiviral Immune Responses-And Viruses Counteract IFN Action. Microbes Infect. 7 (3), 569&#x2013;578. 10.1016/j.micinf.2005.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2005.02.001</ArticleId><ArticleId IdType="pubmed">15792636</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs E., Ward W., Rey S., Law D., Nelson K., Bois M., et al. (2021). Assessment of Potential SARS-CoV-2 Virus Integration into Human Genome Reveals No Significant Impact on RT-qPCR COVID-19 Testing. Proc. Natl. Acad. Sci. 118 (44), e2113065118. 10.1073/pnas.2113065118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113065118</ArticleId><ArticleId IdType="pmc">PMC8612208</ArticleId><ArticleId IdType="pubmed">34702741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberg J., Wang T. C. (2009). Inflammation and Cancer: IL-6 and STAT3 Complete the Link. Cancer cell 15 (2), 79&#x2013;80. 10.1016/j.ccr.2009.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2009.01.009</ArticleId><ArticleId IdType="pmc">PMC3684978</ArticleId><ArticleId IdType="pubmed">19185839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullard J., Dust K., Funk D., Strong J. E., Alexander D., Garnett L., et al. (2020). Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 from Diagnostic Samples. Clin. Infect. Dis. 71 (10), 2663&#x2013;2666. 10.1093/cid/ciaa638</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa638</ArticleId><ArticleId IdType="pmc">PMC7314198</ArticleId><ArticleId IdType="pubmed">32442256</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D., Zerunian M., Polici M., Pucciarelli F., Polidori T., Rucci C., et al. (2020). Chest CT Features of COVID-19 in Rome, Italy. Radiology 296, E79&#x2013;E85. &#x2013;E85. 10.1148/radiol.2020201237</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201237</ArticleId><ArticleId IdType="pmc">PMC7194020</ArticleId><ArticleId IdType="pubmed">32243238</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanzaro M., Fagiani F., Racchi M., Corsini E., Govoni S., Lanni C. (2020). Immune Response in COVID-19: Addressing a Pharmacological challenge by Targeting Pathways Triggered by SARS-CoV-2. Sig Transduct Target. Ther. 5 (1), 84. 10.1038/s41392-020-0191-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0191-1</ArticleId><ArticleId IdType="pmc">PMC7255975</ArticleId><ArticleId IdType="pubmed">32467561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Q., Bournazou E., Sansone P., Berishaj M., Gao S. P., Daly L., et al. (2013). The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis. Neoplasia 15 (7), 848&#x2013;IN45. 10.1593/neo.13706</Citation><ArticleIdList><ArticleId IdType="doi">10.1593/neo.13706</ArticleId><ArticleId IdType="pmc">PMC3689247</ArticleId><ArticleId IdType="pubmed">23814496</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Lau Y. F., Lamirande E. W., Paddock C. D., Bartlett J. H., Zaki S. R., et al. (2010). Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4 + T Cells Are Important in Control of SARS-CoV Infection. J. Virol. 84 (3), 1289&#x2013;1301. 10.1128/JVI.01281-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01281-09</ArticleId><ArticleId IdType="pmc">PMC2812346</ArticleId><ArticleId IdType="pubmed">19906920</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai M., Liu D., Liu M., Zhou F., Li G., Chen Z., et al. (2020). Patients with Cancer Appear More Vulnerable to SARS-COV-2: a Multi-center Study during the COVID-19 Outbreak. Cancer Discov. 10 (6), 20. 10.1158/2159-8290.CD-20-0422</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0422</ArticleId><ArticleId IdType="pmc">PMC7309152</ArticleId><ArticleId IdType="pubmed">32345594</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S., Meschiari M., Gibellini L., Bellinazzi C., Borella R., Fidanza L., et al. (2020). Marked T Cell Activation, Senescence, Exhaustion and Skewing towards TH17 in Patients with COVID-19 Pneumonia. Nat. Commun. 11 (1), 3434. 10.1038/s41467-020-17292-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17292-4</ArticleId><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>de Candia P., Prattichizzo F., Garavelli S., Matarese G. (2021). T Cells: Warriors of SARS-CoV-2 Infection. Trends Immunol. 42 (1), 18&#x2013;30. 10.1016/j.it.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7664351</ArticleId><ArticleId IdType="pubmed">33277181</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wit E., van Doremalen N., Falzarano D., Munster V. J. (2016). SARS and MERS: Recent Insights into Emerging Coronaviruses. Nat. Rev. Microbiol. 14, 523&#x2013;534. 10.1038/nrmicro.2016.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.81</ArticleId><ArticleId IdType="pmc">PMC7097822</ArticleId><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>DeDiego M. L., Nieto-Torres J. L., Regla-Nava J. A., Jimenez-Guarde&#xf1;o J. M., Fernandez-Delgado R., Fett C., et al. (2014). Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival. J. Virol. 88 (2), 913&#x2013;924. 10.1128/jvi.02576-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02576-13</ArticleId><ArticleId IdType="pmc">PMC3911641</ArticleId><ArticleId IdType="pubmed">24198408</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D. M., Kim-Schulze S., Huang H.-H., Beckmann N. D., Nirenberg S., Wang B., et al. (2020). An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival. Nat. Med. 26 (10), 1636&#x2013;1643. 10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B., Wang C., Tan Y., Chen X., Liu Y., Ning L., et al. (2020). Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). Front. Immunol. 11, 827. 10.3389/fimmu.2020.00827</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikid T., Chaudhary S., Goel K., Padda P., Sahu R., Kumar T., et al. (2020). Responding to COVID-19 Pandemic: Why a strong Health System Is Required. Indian J. Med. Res. 151 (2), 140&#x2013;145. 10.4103/ijmr.IJMR_761_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijmr.IJMR_761_20</ArticleId><ArticleId IdType="pmc">PMC7366545</ArticleId><ArticleId IdType="pubmed">32317411</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmerich P., Possel R., Hemmer C. J., Fritzsche C., Geerdes&#x2010;Fenge H., Menge B., et al. (2021). Longitudinal Detection of SARS&#x2010;CoV&#x2010;2&#x2010;specific Antibody Responses with Different Serological Methods. J. Med. Virol. 93 (10), 5816&#x2013;5824. 10.1002/jmv.27113</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27113</ArticleId><ArticleId IdType="pmc">PMC8242665</ArticleId><ArticleId IdType="pubmed">34061367</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslamijouybari M., Heydari K., Maleki I., Moosazadeh M., Hedayatizadeh-Omran A., Vahedi L., et al. (2020). Neutrophil-to-Lymphocyte and Platelet-To-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis. Caspian J. Intern. Med. 11 (Suppl. 1), 531&#x2013;535. 10.22088/cjim.11.0.531</Citation><ArticleIdList><ArticleId IdType="doi">10.22088/cjim.11.0.531</ArticleId><ArticleId IdType="pmc">PMC7780872</ArticleId><ArticleId IdType="pubmed">33425271</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Fang Y., Zhang H., Xie J., Lin M., Ying L., et al. (2020). Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology 296 (2), E115&#x2013;E117. 10.1148/radiol.2020200432</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200432</ArticleId><ArticleId IdType="pmc">PMC7233365</ArticleId><ArticleId IdType="pubmed">32073353</ArticleId></ArticleIdList></Reference><Reference><Citation>Forlani G., Abdallah R., Accolla R. S., Tosi G. (2016). The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-&#x39a;b by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein. J. Virol. 90 (7), 3708&#x2013;3721. 10.1128/jvi.03000-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.03000-15</ArticleId><ArticleId IdType="pmc">PMC4794681</ArticleId><ArticleId IdType="pubmed">26792751</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuertes M. B., Kacha A. K., Kline J., Woo S.-R., Kranz D. M., Murphy K. M., et al. (2011). Host Type I IFN Signals Are Required for Antitumor CD8+ T Cell Responses through CD8&#x3b1;+ Dendritic Cells. J. Exp. Med. 208 (10), 2005&#x2013;2016. 10.1084/jem.20101159</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20101159</ArticleId><ArticleId IdType="pmc">PMC3182064</ArticleId><ArticleId IdType="pubmed">21930765</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghetti C., Ortenzia O., Maddalo M., Altabella L., Sverzellati N. (2020). Dosimetric and Radiation Cancer Risk Evaluation of High Resolution Thorax CT during COVID-19 Outbreak. Physica Med. 80, 119&#x2013;124. 10.1016/j.ejmp.2020.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmp.2020.10.018</ArticleId><ArticleId IdType="pmc">PMC7604119</ArticleId><ArticleId IdType="pubmed">33171381</ArticleId></ArticleIdList></Reference><Reference><Citation>Glebov O. O. (2020). Understanding SARS&#x2010;CoV&#x2010;2 Endocytosis for COVID&#x2010;19 Drug Repurposing. FEBS J. 287, 3664&#x2013;3671. 10.1111/febs.15369</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15369</ArticleId><ArticleId IdType="pmc">PMC7276759</ArticleId><ArticleId IdType="pubmed">32428379</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-j., Ni Z.-y., Hu Y., Liang W.-h., Ou C.-q., He J.-x., et al. (2020). Clinical Characteristics of 2019 Novel Coronavirus Infection in China. MedRxiv.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., et al. (2020). Impaired Type I Interferon Activity and Inflammatory Responses in Severe COVID-19 Patients. Science 369 (6504), 718&#x2013;724. 10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariharan A., Hakeem A. R., Radhakrishnan S., Reddy M. S., Rela M. (2021). The Role and Therapeutic Potential of NF-Kappa-B Pathway in Severe COVID-19 Patients. Inflammopharmacol 29 (1), 91&#x2013;100. 10.1007/s10787-020-00773-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-020-00773-9</ArticleId><ArticleId IdType="pmc">PMC7648206</ArticleId><ArticleId IdType="pubmed">33159646</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris T. J., Grosso J. F., Yen H.-R., Xin H., Kortylewski M., Albesiano E., et al. (2007). Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-dependent Autoimmunity. J. Immunol. 179 (7), 4313&#x2013;4317. 10.4049/jimmunol.179.7.4313</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.7.4313</ArticleId><ArticleId IdType="pubmed">17878325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartenian E., Nandakumar D., Lari A., Ly M., Tucker J. M., Glaunsinger B. A. (2020). The Molecular Virology of Coronaviruses. J. Biol. Chem. 295 (37), 12910&#x2013;12934. 10.1074/jbc.rev120.013930</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.rev120.013930</ArticleId><ArticleId IdType="pmc">PMC7489918</ArticleId><ArticleId IdType="pubmed">32661197</ArticleId></ArticleIdList></Reference><Reference><Citation>Haybar H., Kazemnia K., Rahim F. (2020). Underlying Chronic Disease and COVID-19 Infection: a State-Of-The-Art Review. Jundishapur J. Chronic Dis. Care 9 (2). 10.5812/jjcdc.103452</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/jjcdc.103452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden M. S., Ghosh S. (2008). Shared Principles in NF-&#x39a;b Signaling. Cell 132 (3), 344&#x2013;362. 10.1016/j.cell.2008.01.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.01.020</ArticleId><ArticleId IdType="pubmed">18267068</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q.-F., Xu Y., Li J., Huang Z.-M., Li X.-H., Wang X. (2019). CD8+ T-Cell Exhaustion in Cancer: Mechanisms and New Area for Cancer Immunotherapy. Brief. Funct. Genomics 18 (2), 99&#x2013;106. 10.1093/bfgp/ely006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/ely006</ArticleId><ArticleId IdType="pubmed">29554204</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T., Jurinovic V., Arnreich C., Lipworth B. J., Hellmuth J. C., von Bergwelt-Baildon M., et al. (2020). Elevated Levels of IL-6 and CRP Predict the Need for Mechanical Ventilation in COVID-19. J. Allergy Clin. Immunol. 146 (1), 128&#x2013;136. 10.1016/j.jaci.2020.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7233239</ArticleId><ArticleId IdType="pubmed">32425269</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann A., Kortylewski M., Kujawski M., Zhang C., Reckamp K., Armstrong B., et al. (2010). Targeting Stat3 in the Myeloid Compartment Drastically Improves the In Vivo Antitumor Functions of Adoptively Transferred T Cells. Cancer Res. 70 (19), 7455&#x2013;7464. 10.1158/0008-5472.can-10-0736</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.can-10-0736</ArticleId><ArticleId IdType="pmc">PMC3058618</ArticleId><ArticleId IdType="pubmed">20841481</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T., Murakami M. (2020). COVID-19: a New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity 52 (5), 731&#x2013;733. 10.1016/j.immuni.2020.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7175868</ArticleId><ArticleId IdType="pubmed">32325025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Kr&#xfc;ger N., Mueller M. A., Drosten C., P&#xf6;hlmann S. (2020). The Novel Coronavirus 2019 (2019-nCoV) Uses the SARS-Coronavirus Receptor ACE2 and the Cellular Protease TMPRSS2 for Entry into Target Cells. BioRxiv.</Citation></Reference><Reference><Citation>Hosseini A., Hashemi V., Shomali N., Asghari F., Gharibi T., Akbari M., et al. (2020). Innate and Adaptive Immune Responses against Coronavirus. Biomed. Pharmacother. 132, 110859. 10.1016/j.biopha.2020.110859</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110859</ArticleId><ArticleId IdType="pmc">PMC7580677</ArticleId><ArticleId IdType="pubmed">33120236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss R. S., Moldawer L. L. (2014). Parallels between Cancer and Infectious Disease. N. Engl. J. Med. 371 (4), 380&#x2013;383. 10.1056/NEJMcibr1404664</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr1404664</ArticleId><ArticleId IdType="pubmed">25054723</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh J., Etemadi N., Hollande F., Ernst M., Buchert M. (2017). The JAK/STAT3 axis: A Comprehensive Drug Target for Solid Malignancies. Semin. Cancer Biol. 45, 13&#x2013;22. Elsevier. 10.1016/j.semcancer.2017.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2017.06.001</ArticleId><ArticleId IdType="pubmed">28647610</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata-Kajihara T., Sumimoto H., Kawamura N., Ueda R., Takahashi T., Mizuguchi H., et al. (2011). Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors. J.I. 187 (1), 27&#x2013;36. 10.4049/jimmunol.1002067</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002067</ArticleId><ArticleId IdType="pubmed">21632716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal M., Bangash H. I., Habiba M., Lei Y., Xie T., Sun J., et al. (2021). Immune Dysregulation and System Pathology in COVID-19. Virulence 12 (1), 918&#x2013;936. 10.1080/21505594.2021.1898790</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2021.1898790</ArticleId><ArticleId IdType="pmc">PMC7993139</ArticleId><ArticleId IdType="pubmed">33757410</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D. E., O'Keefe R. A., Grandis J. R. (2018). Targeting the IL-6/JAK/STAT3 Signalling axis in Cancer. Nat. Rev. Clin. Oncol. 15 (4), 234&#x2013;248. 10.1038/nrclinonc.2018.8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2018.8</ArticleId><ArticleId IdType="pmc">PMC5858971</ArticleId><ArticleId IdType="pubmed">29405201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazachenka A., Kassiotis G. (2021). SARS-CoV-2-Host Chimeric RNA-Sequencing Reads Do Not Necessarily Arise from Virus Integration into the Host DNA. Front. Microbiol. 12 (1367). 10.3389/fmicb.2021.676693</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.676693</ArticleId><ArticleId IdType="pmc">PMC8206523</ArticleId><ArticleId IdType="pubmed">34149667</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazazian H. H., Moran J. V., Moran J. V. (2017). Mobile DNA in Health and Disease. N. Engl. J. Med. 377 (4), 361&#x2013;370. 10.1056/NEJMra1510092</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1510092</ArticleId><ArticleId IdType="pmc">PMC5980640</ArticleId><ArticleId IdType="pubmed">28745987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R., Haasbach E., Lueftenegger D., Heyken W. T., Ocker M., Planz O. (2020). NF-&#x3ba;B Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Front. Immunol. 11, 598444. 10.3389/fimmu.2020.598444</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.598444</ArticleId><ArticleId IdType="pmc">PMC7759159</ArticleId><ArticleId IdType="pubmed">33362782</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch J., Steinle A., Watzl C., Mandelboim O. (2013). Activating Natural Cytotoxicity Receptors of Natural Killer Cells in Cancer and Infection. Trends Immunol. 34 (4), 182&#x2013;191. 10.1016/j.it.2013.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2013.01.003</ArticleId><ArticleId IdType="pubmed">23414611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortylewski M., Kujawski M., Wang T., Wei S., Zhang S., Pilon-Thomas S., et al. (2005). Inhibiting Stat3 Signaling in the Hematopoietic System Elicits Multicomponent Antitumor Immunity. Nat. Med. 11 (12), 1314&#x2013;1321. 10.1038/nm1325</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1325</ArticleId><ArticleId IdType="pubmed">16288283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari N., Dwarakanath B. S., Das A., Bhatt A. N. (2016). Role of Interleukin-6 in Cancer Progression and Therapeutic Resistance. Tumor Biol. 37 (9), 11553&#x2013;11572. 10.1007/s13277-016-5098-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-016-5098-7</ArticleId><ArticleId IdType="pubmed">27260630</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A. G., Lorenc A., del Molino del Barrio I., Das A., Fish M., Monin L., et al. (2020). A Dynamic COVID-19 Immune Signature Includes Associations with Poor Prognosis. Nat. Med. 26 (10), 1623&#x2013;1635. 10.1038/s41591-020-1038-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Wu M. (2021). Pattern Recognition Receptors in Health and Diseases. Sig Transduct Target. Ther. 6 (1), 291. 10.1038/s41392-021-00687-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00687-0</ArticleId><ArticleId IdType="pmc">PMC8333067</ArticleId><ArticleId IdType="pubmed">34344870</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Fan Y., Lai Y., Han T., Li Z., Zhou P., et al. (2020). Coronavirus Infections and Immune Responses. J. Med. Virol. 92 (4), 424&#x2013;432. 10.1002/jmv.25685</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25685</ArticleId><ArticleId IdType="pmc">PMC7166547</ArticleId><ArticleId IdType="pubmed">31981224</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Fan Y., Lai Y., Han T., Li Z., Zhou P., et al. (2020). Coronavirus Infections and Immune Responses. J. Med. Virol. 92 (4), 424&#x2013;432. 10.1002/jmv.25685</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25685</ArticleId><ArticleId IdType="pmc">PMC7166547</ArticleId><ArticleId IdType="pubmed">31981224</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Wang X., Lv T. (2020). Prolonged SARS&#x2010;CoV&#x2010;2 RNA Shedding: Not a Rare Phenomenon. J. Med. Virol. 92 (11), 2286&#x2013;2287. 10.1002/jmv.25952</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25952</ArticleId><ArticleId IdType="pmc">PMC7267144</ArticleId><ArticleId IdType="pubmed">32347980</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Geng M., Peng Y., Meng L., Lu S. (2020). Molecular Immune Pathogenesis and Diagnosis of COVID-19. J. Pharm. Anal. 10, 102&#x2013;108. 10.1016/j.jpha.2020.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7104082</ArticleId><ArticleId IdType="pubmed">32282863</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y., Zhou Y., Shen P. (2004). NF-kappaB and its Regulation on the Immune System. Cell Mol Immunol 1 (5), 343&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">16285893</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Q.-J., Ye L.-B., Timani K. A., Zeng Y.-C., She Y.-L., Ye L., et al. (2005). Activation of NF-kappaB by the Full-Length Nucleocapsid Protein of the SARS Coronavirus. Acta Biochim. Biophys. Sinica 37 (9), 607&#x2013;612. 10.1111/j.1745-7270.2005.00082.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7270.2005.00082.x</ArticleId><ArticleId IdType="pmc">PMC7109668</ArticleId><ArticleId IdType="pubmed">16143815</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S.-C. (2017). NF-&#x3ba;B Signaling in Inflammation. Sig Transduct Target. Ther. 2, 2. 10.1038/sigtrans.2017.23</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Li Q., Cai S., Peng H., Huyan T., Yang H. (2021). The Role of NK Cells in Fighting the Virus Infection and Sepsis. Int. J. Med. Sci. 18 (14), 3236&#x2013;3248. 10.7150/ijms.59898</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.59898</ArticleId><ArticleId IdType="pmc">PMC8364442</ArticleId><ArticleId IdType="pubmed">34400893</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrack P., Kappler J., Mitchell T. (1999). Type I Interferons Keep Activated T Cells Alive. J. Exp. Med. 189 (3), 521&#x2013;530. 10.1084/jem.189.3.521</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.189.3.521</ArticleId><ArticleId IdType="pmc">PMC2192920</ArticleId><ArticleId IdType="pubmed">9927514</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney E. F., Smith K. G. (2016). T Cell Exhaustion and Immune-Mediated Disease-The Potential for Therapeutic Exhaustion. Curr. Opin. Immunol. 43, 74&#x2013;80. 10.1016/j.coi.2016.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2016.09.005</ArticleId><ArticleId IdType="pubmed">27744240</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin-Drubin M. E., Munger K. (2008). Viruses Associated with Human Cancer. Biochim. Biophys. Acta (Bba) - Mol. Basis Dis. 1782 (3), 127&#x2013;150. 10.1016/j.bbadis.2007.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2007.12.005</ArticleId><ArticleId IdType="pmc">PMC2267909</ArticleId><ArticleId IdType="pubmed">18201576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina M. J., Parker R., Larremore D. B. (2020). Rethinking Covid-19 Test Sensitivity - A Strategy for Containment. N. Engl. J. Med. 383 (22), e120. 10.1056/nejmp2025631</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmp2025631</ArticleId><ArticleId IdType="pubmed">32997903</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasaki T., Hara M., Nakanishi H., Takahashi H., Sato M., Takeyama H. (2014). Interleukin-6 Released by colon Cancer-Associated Fibroblasts Is Critical for Tumour Angiogenesis: Anti-interleukin-6 Receptor Antibody Suppressed Angiogenesis and Inhibited Tumour-Stroma Interaction. Br. J. Cancer 110 (2), 469&#x2013;478. 10.1038/bjc.2013.748</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2013.748</ArticleId><ArticleId IdType="pmc">PMC3899773</ArticleId><ArticleId IdType="pubmed">24346288</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa K., Makino S. (2021). Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression. Cells 10 (2), 300. 10.3390/cells10020300</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020300</ArticleId><ArticleId IdType="pmc">PMC7912902</ArticleId><ArticleId IdType="pubmed">33540583</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi H., Taniguchi T., Yanai H. (2018). The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harb Perspect. Biol. 10 (11), a028423. 10.1101/cshperspect.a028423</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028423</ArticleId><ArticleId IdType="pmc">PMC6211389</ArticleId><ArticleId IdType="pubmed">28963109</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozawa H., Chiu C., Hanahan D. (2006). Infiltrating Neutrophils Mediate the Initial Angiogenic Switch in a Mouse Model of Multistage Carcinogenesis. Proc. Natl. Acad. Sci. 103 (33), 12493&#x2013;12498. 10.1073/pnas.0601807103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0601807103</ArticleId><ArticleId IdType="pmc">PMC1531646</ArticleId><ArticleId IdType="pubmed">16891410</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckinghaus A., Ghosh S. (2009). The NF- B Family of Transcription Factors and its Regulation. Cold Spring Harbor Perspect. Biol. 1 (4), a000034. 10.1101/cshperspect.a000034</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000034</ArticleId><ArticleId IdType="pmc">PMC2773619</ArticleId><ArticleId IdType="pubmed">20066092</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Jiang X., Yang L., Chen L., Zeng X., Liu G., et al. (2021). SARS-CoV-2-specific Immune Response in COVID-19 Convalescent Individuals. Signal. Transduction Targeted Ther. 6, 256. 10.1038/s41392-021-00686-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00686-1</ArticleId><ArticleId IdType="pmc">PMC8261819</ArticleId><ArticleId IdType="pubmed">34234102</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry R., Gifford R. J., Lytras S., Ray S. C., Coin L. J. M. (2021). No Evidence of SARS-CoV-2 Reverse Transcription and Integration as the Origin of Chimeric Transcripts in Patient Tissues. Proc. Natl. Acad. Sci. USA 118 (33), e2109066118. 10.1073/pnas.2109066118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109066118</ArticleId><ArticleId IdType="pmc">PMC8379926</ArticleId><ArticleId IdType="pubmed">34344759</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen S. F., Ho Y.-C. (2020). SARS-CoV-2: a Storm Is Raging. J. Clin. Invest. 130 (5), 2202&#x2013;2205. 10.1172/jci137647</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci137647</ArticleId><ArticleId IdType="pmc">PMC7190904</ArticleId><ArticleId IdType="pubmed">32217834</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelkmans L., Helenius A. (2003). Insider Information: what Viruses Tell Us about Endocytosis. Curr. Opin. Cel. Biol. 15 (4), 414&#x2013;422. 10.1016/s0955-0674(03)00081-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0955-0674(03)00081-4</ArticleId><ArticleId IdType="pubmed">12892781</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman S., Netland J. (2009). Coronaviruses post-SARS: Update on Replication and Pathogenesis. Nat. Rev. Microbiol. 7 (6), 439&#x2013;450. 10.1038/nrmicro2147</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2147</ArticleId><ArticleId IdType="pmc">PMC2830095</ArticleId><ArticleId IdType="pubmed">19430490</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer M., de Martel C., Vignat J., Ferlay J., Bray F., Franceschi S. (2016). Global burden of Cancers Attributable to Infections in 2012: a Synthetic Analysis. Lancet Glob. Health 4 (9), e609&#x2013;e616. 10.1016/s2214-109x(16)30143-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2214-109x(16)30143-7</ArticleId><ArticleId IdType="pubmed">27470177</ArticleId></ArticleIdList></Reference><Reference><Citation>Power S. P., Moloney F., Twomey M., James K., O&#x2019;Connor O. J., Maher M. M. (2016). Computed Tomography and Patient Risk: Facts, Perceptions and Uncertainties. Wjr 8 (12), 902&#x2013;915. 10.4329/wjr.v8.i12.902</Citation><ArticleIdList><ArticleId IdType="doi">10.4329/wjr.v8.i12.902</ArticleId><ArticleId IdType="pmc">PMC5183924</ArticleId><ArticleId IdType="pubmed">28070242</ArticleId></ArticleIdList></Reference><Reference><Citation>Prompetchara E., Ketloy C., Palaga T. (2020). Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned from SARS and MERS Epidemic. Asian Pac. J. Allergy Immunol. 38 (1), 1&#x2013;9. 10.12932/AP-200220-0772</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP-200220-0772</ArticleId><ArticleId IdType="pubmed">32105090</ArticleId></ArticleIdList></Reference><Reference><Citation>Radpour A., Bahrami-Motlagh H., Taaghi M. T., Sedaghat A., Karimi M. A., Hekmatnia A., et al. (2020). COVID-19 Evaluation by Low-Dose High Resolution CT Scans Protocol. Acad. Radiol. 27 (6), 901. 10.1016/j.acra.2020.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.04.016</ArticleId><ArticleId IdType="pmc">PMC7164844</ArticleId><ArticleId IdType="pubmed">32335002</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi J.-F., Lu Z. Y., Massart C., Levon K. (2021). Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer. Front. Immunol. 12, 595722. 10.3389/fimmu.2021.595722</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.595722</ArticleId><ArticleId IdType="pmc">PMC7940508</ArticleId><ArticleId IdType="pubmed">33708198</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G., Aneja R. (2021). Cancer as a Prospective Sequela of Long COVID&#x2010;19. Bioessays 43 (6), 2000331. 10.1002/bies.202000331</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000331</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="pubmed">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar L., Kashiwada T., Krejci P., Meyer A. N., Casale M., Hallowell M., et al. (2014). Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGF&#x3b2;-Activated Kinase 1 Tyrosine Phosphorylation and NF&#x3ba;B Signaling in Multiple Myeloma and Bladder Cancer. PLoS One 9 (1), e86470. 10.1371/journal.pone.0086470</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0086470</ArticleId><ArticleId IdType="pmc">PMC3900522</ArticleId><ArticleId IdType="pubmed">24466111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangfelt O., Erickson S., Castro J., Heiden T., Gustafsson A., Einhorn S., et al. (1999). Molecular Mechanisms Underlying Interferon-Alpha-Induced G0/G1 Arrest: CKI-Mediated Regulation of G1 Cdk-Complexes and Activation of Pocket Proteins. Oncogene 18 (18), 2798&#x2013;2810. 10.1038/sj.onc.1202609</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1202609</ArticleId><ArticleId IdType="pubmed">10362250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau A., Lau R., Cabrita M. A., Nolan E., Crooks P. A., Visvader J. E., et al. (2016). Persistent Activation of NF-&#x39a;b in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage. Cell stem cell 19 (1), 52&#x2013;65. 10.1016/j.stem.2016.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC6850408</ArticleId><ArticleId IdType="pubmed">27292187</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler C., Levy D. E., Decker T. (2007). JAK-STAT Signaling: from Interferons to Cytokines. J. Biol. Chem. 282 (28), 20059&#x2013;20063. 10.1074/jbc.r700016200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.r700016200</ArticleId><ArticleId IdType="pubmed">17502367</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber R. D., Old L. J., Smyth M. J. (2011). Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion. Science 331 (6024), 1565&#x2013;1570. 10.1126/science.1203486</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1203486</ArticleId><ArticleId IdType="pubmed">21436444</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Paschold L., Simnica D., Mohme M., Willscher E., von Wenserski L., et al. (2020). Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease. Immunity 53 (2), 442e4&#x2013;455. 10.1016/j.immuni.2020.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.024</ArticleId><ArticleId IdType="pmc">PMC7324317</ArticleId><ArticleId IdType="pubmed">32668194</ArticleId></ArticleIdList></Reference><Reference><Citation>Smits N., Rasmussen J., Bodea G. O., Amarilla A. A., Gerdes P., Sanchez-Luque F. J., et al. (2021). No Evidence of Human Genome Integration of SARS-CoV-2 Found by Long-Read DNA Sequencing. Cel Rep. 36 (7), 109530. 10.1016/j.celrep.2021.109530</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109530</ArticleId><ArticleId IdType="pmc">PMC8316065</ArticleId><ArticleId IdType="pubmed">34380018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi C., Alsafi Z., O&#x2019;Neill N., Khan M., Kerwan A., Al-Jabir A., et al. (2020). World Health Organization Declares Global Emergency: A Review of the 2019 Novel Coronavirus (COVID-19). Int. J. Surg. 76, 71&#x2013;76. 10.1016/j.ijsu.2020.02.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.02.034</ArticleId><ArticleId IdType="pmc">PMC7105032</ArticleId><ArticleId IdType="pubmed">32112977</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani S., Tabibzadeh A., Zakeri A., Zakeri A. M., Latifi T., Shabani M., et al. (2021). COVID-19 Associated central Nervous System Manifestations, Mental and Neurological Symptoms: a Systematic Review and Meta-Analysis. Rev. Neurosciences 32 (3), 351&#x2013;361. 10.1515/revneuro-2020-0108</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0108</ArticleId><ArticleId IdType="pubmed">33618441</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.-W., Zhang C., Fan X., Meng F.-P., Xu Z., Xia P., et al. (2020). Immunological and Inflammatory Profiles in Mild and Severe Cases of COVID-19. Nat. Commun. 11 (1), 3410. 10.1038/s41467-020-17240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17240-2</ArticleId><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Mazzieri R., Yang T., Gobe G. C. (2017). Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition. Front. Immunol. 8, 1106. 10.3389/fimmu.2017.01106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01106</ArticleId><ArticleId IdType="pmc">PMC5601389</ArticleId><ArticleId IdType="pubmed">28955335</ArticleId></ArticleIdList></Reference><Reference><Citation>Stetson D. B., Medzhitov R. (2006). Type I Interferons in Host Defense. Immunity 25 (3), 373&#x2013;381. 10.1016/j.immuni.2006.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.08.007</ArticleId><ArticleId IdType="pubmed">16979569</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng Y., Ross J. L., Cowell J. K. (2014). The Involvement of JAK-STAT3 in Cell Motility, Invasion, and Metastasis. Jak-stat 3 (1), e28086. 10.4161/jkst.28086</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/jkst.28086</ArticleId><ArticleId IdType="pmc">PMC3995737</ArticleId><ArticleId IdType="pubmed">24778926</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas A. J., Harris C. C. (2016). Biomarker Development in the Precision Medicine Era: Lung Cancer as a Case Study. Nat. Rev. Cancer 16 (8), 525&#x2013;537. 10.1038/nrc.2016.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2016.56</ArticleId><ArticleId IdType="pmc">PMC6662593</ArticleId><ArticleId IdType="pubmed">27388699</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter M., Liang S., Ghosh S., Hornsby P. J., Li R. (2009). Interleukin 6 Secreted from Adipose Stromal Cells Promotes Migration and Invasion of Breast Cancer Cells. Oncogene 28 (30), 2745&#x2013;2755. 10.1038/onc.2009.130</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2009.130</ArticleId><ArticleId IdType="pmc">PMC2806057</ArticleId><ArticleId IdType="pubmed">19483720</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther W., Kobelt D., Bauer L., Aumann J., Stein U. (2015). Chemosensitization by Diverging Modulation by Short-Term and Long-Term TNF-&#x3b1; Action on ABCB1 Expression and NF-&#x39a;b Signaling in colon Cancer. Int. J. Oncol. 47 (6), 2276&#x2013;2285. 10.3892/ijo.2015.3189</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2015.3189</ArticleId><ArticleId IdType="pubmed">26463665</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Lu X.-J., Sun B. (2017). The Pros and Cons of Dying Tumour Cells in Adaptive Immune Responses. Nat. Rev. Immunol. 17 (9), 591. 10.1038/nri.2017.87</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.87</ArticleId><ArticleId IdType="pubmed">28757605</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P. C. Y., Huang Y., Lau S. K. P., Yuen K.-Y. (2010). Coronavirus Genomics and Bioinformatics Analysis. viruses 2 (8), 1804&#x2013;1820. 10.3390/v2081803</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v2081803</ArticleId><ArticleId IdType="pmc">PMC3185738</ArticleId><ArticleId IdType="pubmed">21994708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., et al. (2020). A New Coronavirus Associated with Human Respiratory Disease in China. Nature 579 (7798), 265&#x2013;269. 10.1038/s41586-020-2008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J., Gong Y., Chen Y., Yu D., Wang X., Zhang X., et al. (2017). IL-6 Promotes Epithelial-To-Mesenchymal Transition of Human Peritoneal Mesothelial Cells Possibly through the JAK2/STAT3 Signaling Pathway. Am. J. Physiology-Renal Physiol. 313 (2), F310&#x2013;F318. 10.1152/ajprenal.00428.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00428.2016</ArticleId><ArticleId IdType="pubmed">28490530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Liu S., Liu J., Zhang Z., Wan X., Huang B., et al. (2020). COVID-19: Immunopathogenesis and Immunotherapeutics. Sig Transduct Target. Ther. 5 (1), 128. 10.1038/s41392-020-00243-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00243-2</ArticleId><ArticleId IdType="pmc">PMC7381863</ArticleId><ArticleId IdType="pubmed">32712629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang N., Shen H.-M. (2020). Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19. Int. J. Biol. Sci. 16 (10), 1724&#x2013;1731. 10.7150/ijbs.45498</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.45498</ArticleId><ArticleId IdType="pmc">PMC7098027</ArticleId><ArticleId IdType="pubmed">32226290</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap J. K. Y., Moriyama M., Iwasaki A. (2020). Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19. J.I. 205 (2), 307&#x2013;312. 10.4049/jimmunol.2000513</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000513</ArticleId><ArticleId IdType="pmc">PMC7343621</ArticleId><ArticleId IdType="pubmed">32493814</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye C.-H., Hsu W.-L., Peng G.-R., Yu W.-C., Lin W.-C., Hu S., et al. (2021). Role of the Immune Microenvironment in SARS-CoV-2 Infection. Cel Transpl. 30, 096368972110106. 10.1177/09636897211010632</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09636897211010632</ArticleId><ArticleId IdType="pmc">PMC8114753</ArticleId><ArticleId IdType="pubmed">33949207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M., Song Y., Pan S., Chu M., Wang Z.-W., Zhu X. (2020). Evolving Roles of Lysyl Oxidase Family in Tumorigenesis and Cancer Therapy. Pharmacol. Ther. 215, 107633. 10.1016/j.pharmthera.2020.107633</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107633</ArticleId><ArticleId IdType="pubmed">32693113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Kortylewski M., Pardoll D. (2007). Crosstalk between Cancer and Immune Cells: Role of STAT3 in the Tumour Microenvironment. Nat. Rev. Immunol. 7 (1), 41&#x2013;51. 10.1038/nri1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1995</ArticleId><ArticleId IdType="pubmed">17186030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Pardoll D., Jove R. (2009). STATs in Cancer Inflammation and Immunity: a Leading Role for STAT3. Nat. Rev. Cancer 9 (11), 798&#x2013;809. 10.1038/nrc2734</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2734</ArticleId><ArticleId IdType="pmc">PMC4856025</ArticleId><ArticleId IdType="pubmed">19851315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafer M. M., El-Mahallawy H. A., Ashour H. M. (2021). Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers. Microorganisms 9 (1), 159. 10.3390/microorganisms9010159</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9010159</ArticleId><ArticleId IdType="pmc">PMC7827860</ArticleId><ArticleId IdType="pubmed">33445583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapatka M., Borozan I., Borozan I., Brewer D. S., Iskar M., Grundhoff A., et al. (2020). The Landscape of Viral Associations in Human Cancers. Nat. Genet. 52 (3), 320&#x2013;330. 10.1038/s41588-019-0558-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0558-9</ArticleId><ArticleId IdType="pmc">PMC8076016</ArticleId><ArticleId IdType="pubmed">32025001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Richards A., Barrasa M. I., Hughes S. H., Young R. A., Jaenisch R. (2021). Reverse-transcribed SARS-CoV-2 RNA Can Integrate into the Genome of Cultured Human Cells and Can Be Expressed in Patient-Derived Tissues. Proc. Natl. Acad. Sci. 118 (21), e2105968118. 10.1073/pnas.2105968118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Richards A., Khalil A., Wogram E., Ma H., Young R. A., et al. (2020). SARS-CoV-2 RNA Reverse-Transcribed and Integrated into the Human Genome. bioRxiv.</Citation></Reference><Reference><Citation>Zhang Q., Lenardo M. J., Baltimore D. (2017). 30 Years of NF-&#x39a;b: A Blossoming of Relevance to Human Pathobiology. Cell 168 (1-2), 37&#x2013;57. 10.1016/j.cell.2016.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5268070</ArticleId><ArticleId IdType="pubmed">28086098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Gao Y., Wang G., Song G., Liu S., Sun D., et al. (2020). Functional Exhaustion of Antiviral Lymphocytes in COVID-19 Patients. Cel Mol Immunol 17 (5), 533&#x2013;535. 10.1038/s41423-020-0402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T., Su T. T., Mudianto T., Wang J. (2020). Immune Asynchrony in COVID-19 Pathogenesis and Potential Immunotherapies. J. Exp. Med. 217 (10). 10.1084/jem.20200674</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200674</ArticleId><ArticleId IdType="pmc">PMC7481961</ArticleId><ArticleId IdType="pubmed">32910820</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Ye Q. (2021). Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front. Immunol. 12, 646333. 10.3389/fimmu.2021.646333</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.646333</ArticleId><ArticleId IdType="pmc">PMC8121250</ArticleId><ArticleId IdType="pubmed">33995364</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>